Evaluation of treatment response to niraparib in patients with platinum-sensitive recurrent ovarian cancer and measurable lesions at baseline: a sub-analysis of the phase III NORA trial
Year: 2021
Type: article
Source: Gynecologic Oncology
Authors: Rutie Yin, Xiaohua Wu, Jianqing Zhu, Jiaxin Yang, Ting Deng, Jing Wang, Lingying Wu, Ziling Liu, Yunong Gao, Danbo Wang, Ge Lou, Hongying Yang, Qi Zhou, Beihua Kong, Yi Huang, Lipai Chen, Guiling Li, Ruifang An, Ke Wang, Yu Zhang, Xiaojian Yan, Xin Lu, Li Wang, Tao Tan, Juan Dong
Institutions: West China Second University Hospital of Sichuan University, Fudan University Shanghai Cancer Center, University of Chinese Academy of Sciences, Peking Union Medical College Hospital, Sun Yat-sen University Cancer Center, Central South University, Hunan Cancer Hospital, First Hospital of Jilin University, Peking University Cancer Hospital, China Medical University, Third Affiliated Hospital of Harbin Medical University, Kunming Medical University, Chongqing University, Chongqing Cancer Hospital, Qilu Hospital of Shandong University, Hubei Cancer Hospital, Guangzhou Medical University Cancer Hospital, Wuhan Union Hospital, First Affiliated Hospital of Xi'an Jiaotong University, Tianjin Medical University Cancer Institute and Hospital, Xiangya Hospital Central South University, First Affiliated Hospital of Wenzhou Medical University, Fudan University, Obstetrics and Gynecology Hospital of Fudan University, Zhengzhou University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3197232745